Title : Addition of high-dose methotrexate to standard treatment for patients with high-risk diffuse large B-cell lymphoma contributes to improved freedom from progression and survival but does not prevent central nervous system relapse.

Pub. Date : 2019 Aug

PMID : 30689468






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Combination of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) is regarded as standard care for diffuse large B-cell lymphoma (DLBCL) and upfront intensification of therapy is still controversial. Prednisone DNA damage inducible transcript 3 Homo sapiens